SCHEMBL789925

SCHEMBL789925

CCOC(OC(C)N)C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 2/20 0.37
GABRD O14764 2/20 0.37
GABRA1 P14867 2/20 0.37
GABRB1 P18505 2/20 0.37
GABRG2 P18507 2/20 0.37
GABRB3 P28472 2/20 0.37
GABRA5 P31644 2/20 0.37
GABRA3 P34903 2/20 0.37
GABRA2 P47869 2/20 0.37
GABRB2 P47870 2/20 0.37
GABRA4 P48169 2/20 0.37
GABRE P78334 2/20 0.37
GABRA6 Q16445 2/20 0.37
GABRG1 Q8N1C3 2/20 0.37
GABRG3 Q99928 2/20 0.37
GABRQ Q9UN88 2/20 0.37
SLC7A5 Q01650 2/20 0.37
LMNA P02545 1/20 0.35
SLC1A3 P43003 3/20 0.33
SLC1A2 P43004 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1172257 0.82 LMNA (0.38) LMNAPPARA
SCHEMBL15174708 0.78 LMNA (0.35) LMNAPPARA
SCHEMBL27949726 0.78 LMNA (0.35) LMNAPPARA
SCHEMBL1664822 0.78 LMNA (0.40) LMNASLC1A3SLC1A2SLC1A1PPARA
SCHEMBL1702793 0.78 THRB (0.42) LMNAPPARA
SCHEMBL27879272 0.76 THRB (0.40) LMNAPPARA
SCHEMBL27895981 0.76 THRB (0.40) LMNAPPARA
SCHEMBL28762234 0.76 THRB (0.40) LMNAPPARA
SCHEMBL303947 0.74
SCHEMBL27572634 0.74 PPARA (0.31) LMNAPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 232 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4731606-A1 IONIZABLE THIOLIPIDS AND USES THEREOF BioNTech SE (DE) 2026-04-29 EP claimed
WO-2025261607-A1 PARTICLES, COMPOSITIONS AND METHODS BioNTech SE (DE) 2025-12-26 WO claimed
EP-4658250-A1 COMPOSITIONS AND METHODS BioNTech SE (DE) 2025-12-10 EP claimed
EP-4658248-A1 COMPOSITIONS AND METHODS BioNTech SE (DE) 2025-12-10 EP claimed
EP-4658249-A1 COMPOSITIONS AND METHODS BioNTech SE (DE) 2025-12-10 EP claimed
WO-2025228975-A1 PARTICLES, COMPOSITIONS AND METHODS BioNTech SE (DE) 2025-11-06 WO claimed
WO-2025133105-A1 COMPOSITIONS AND METHODS BIONTECH DELIVERY TECHNOLOGIES GMBH (DE) 2025-06-26 WO claimed
WO-2025093665-A1 PARTICLES, COMPOSITIONS AND METHODS BioNTech SE (DE) 2025-05-08 WO claimed
WO-2025027089-A1 IONIZABLE THIOLIPIDS AND USES THEREOF BioNTech SE (DE) 2025-02-06 WO claimed
WO-2025026545-A1 IONIZABLE THIOPLIPIDS AND USES THEREOF BioNTech SE (DE) 2025-02-06 WO claimed
WO-2024160828-A1 COMPOSITIONS AND METHODS BioNTech SE (DE) 2024-08-08 WO claimed
WO-2024160829-A1 COMPOSITIONS AND METHODS BioNTech SE (DE) 2024-08-08 WO claimed
WO-2024160826-A1 COMPOSITIONS AND METHODS BioNTech SE (DE) 2024-08-08 WO claimed
US-20150299700-A1 EMBEDDED CHIMERIC PEPTIDE NUCLEIC ACIDS AND USES THEREOF MOUNT SINAI SCHOOL OF MEDICINE (US) 2015-10-22 US claimed
US-20130078227-A1 EMBEDDED CHIMERIC PEPTIDE NUCLEIC ACIDS AND USES THEREOF ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 2013-03-28 US claimed
WO-2012075027-A1 EMBEDDED CHIMERIC PEPTIDE NUCLEIC ACIDS FOR GENERATION OF INDUCED PLURIPOTENT STEM CELLS MOUNT SINAI SCHOOL OF MEDICINE (US) 2012-06-07 WO claimed
WO-2011103215-A1 EMBEDDED CHIMERIC PEPTIDE NUCLEIC ACIDS AND USE THEREOF MOUNT SINAI SCHOOL OF MEDICINE (US) 2011-08-25 WO claimed
EP-4731606-A1 IONIZABLE THIOLIPIDS AND USES THEREOF BioNTech SE (DE) 2026-04-29 EP disclosed
WO-2008151257-A2 AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS SYNERGY PHARMACEUTICALS INC. (US) 2008-12-11 WO disclosed
WO-2002042259-A2 METHODS OF SYNTHESIZING AND USING DERIVATIVES OF [2-(2-AMINOETHOXY)ETHOXY] ACETIC ACID UNIVERSITY OF MARYLAND, BALTIMORE (US) 2002-05-30 WO disclosed